Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Story

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
ACS Infectious Diseases|February 22, 2024
Understanding Antisense Oligonucleotide Efficiency in Inhibiting Prokaryotic Gene ExpressionSandra Story, Sayantan Bhaduri, Sudakshina Ganguly, et al.
Medchemcomm|August 16, 2018
Targeting miRNA by tunable small molecule binders: peptidic aminosugar mediated interference in miR-21 biogenesis reverts epithelial to mesenchymal transitionArpita Ghosh, Natalya Degyatoreva, Casey Kukielski, et al.
ACS Infectious Diseases|January 20, 2017
Antimicrobial Activity, AME Resistance, and A-Site Binding Studies of Anthraquinone-Neomycin ConjugatesNatalya N Degtyareva, Changjun Gong, Sandra Story, et al.
Journal of Medicinal Chemistry|May 18, 2017
Selective Inhibition of Escherichia coli RNA and DNA Topoisomerase I by Hoechst 33258 Derived Mono- and BisbenzimidazolesNihar Ranjan, Sandra Story, Geraldine Fulcrand, et al.
European Journal of Medicinal Chemistry|December 12, 2018
Synthesis, antimicrobial activity, attenuation of aminoglycoside resistance in MRSA, and ribosomal A-site binding of pyrene-neomycin conjugatesSandra Story, Michael J Skriba, Krishnagopal Maiti, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
ACS Infectious Diseases|February 22, 2024
Understanding Antisense Oligonucleotide Efficiency in Inhibiting Prokaryotic Gene ExpressionSandra Story, Sayantan Bhaduri, Sudakshina Ganguly, et al.
Medchemcomm|August 16, 2018
Targeting miRNA by tunable small molecule binders: peptidic aminosugar mediated interference in miR-21 biogenesis reverts epithelial to mesenchymal transitionArpita Ghosh, Natalya Degyatoreva, Casey Kukielski, et al.
ACS Infectious Diseases|January 20, 2017
Antimicrobial Activity, AME Resistance, and A-Site Binding Studies of Anthraquinone-Neomycin ConjugatesNatalya N Degtyareva, Changjun Gong, Sandra Story, et al.
Journal of Medicinal Chemistry|May 18, 2017
Selective Inhibition of Escherichia coli RNA and DNA Topoisomerase I by Hoechst 33258 Derived Mono- and BisbenzimidazolesNihar Ranjan, Sandra Story, Geraldine Fulcrand, et al.
European Journal of Medicinal Chemistry|December 12, 2018
Synthesis, antimicrobial activity, attenuation of aminoglycoside resistance in MRSA, and ribosomal A-site binding of pyrene-neomycin conjugatesSandra Story, Michael J Skriba, Krishnagopal Maiti, et al.
Pageof 2